PTC Therapeutics, Inc. PTCT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

74/100

5/7 Pass

SharesGrow Intrinsic Value

There have been 50 recent insider transactions recorded for PTC Therapeutics, Inc. (PTCT), including 9 buys and 40 sells. Total insider buying was valued at $13.96M and total insider selling at $6.06M.

Notable insiders with recent activity include Golden Lee Scott, Almstead Neil Gregory, Chutter Jessica Caroline. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — PTCT

Date	Name	Role	Transaction	Shares	Avg. Price	Value	Shares Owned
2026-04-02	Golden Lee Scott	EVP & Chief Medical Officer	Informative Sell	829	$67.99	$56.36K	79,115
2026-04-01	Almstead Neil Gregory	Chief Technical Ops Officer	Informative Sell	80	$70.30	$5.62K	60,137
2026-03-24	Chutter Jessica Caroline	Officer	Unknown	-	-	-	-
2026-03-24	Chutter Jessica Caroline	Director	RSU Award	2,896	$64.54	$186.91K	2,896
2026-03-12	Klein Matthew B.	Chief Executive Officer	Informative Sell	2,662	$64.08	$170.58K	396,920
2026-03-11	Klein Matthew B.	Chief Executive Officer	RSU Award	12,500	-	-	399,582
2026-03-10	Okey Stephanie	Director	Option Exercise (Sell)	14,000	$33.63	$470.82K	-
2026-03-05	Almstead Neil Gregory	Chief Technical Ops Officer	Informative Sell	3,989	$63.38	$252.82K	2,737
2026-03-05	Golden Lee Scott	EVP & Chief Medical Officer	Informative Sell	10,000	$63.38	$633.8K	79,944
2026-03-05	Okey Stephanie	Director	Informative Sell	6,333	$63.38	$401.39K	8,000
2026-02-19	Boulding Mark Elliott	Exec. VP and CLO	Informative Sell	590	$69.82	$41.19K	105,212
2026-02-18	Boulding Mark Elliott	Exec. VP and CLO	Informative Sell	3,081	$69.36	$213.7K	108,231
2026-02-18	Pauwels Eric	Chief Business Officer	Informative Sell	3,019	$69.36	$209.4K	77,122
2026-02-18	Almstead Neil Gregory	Chief Technical Ops Officer	Informative Sell	65	$69.36	$4.51K	6,726
2026-02-18	Golden Lee Scott	EVP & Chief Medical Officer	Informative Sell	2,484	$69.36	$172.29K	89,944
2026-02-18	Utter Christine Marie	SVP, Chief Accounting Officer	Informative Sell	2,494	$69.36	$172.98K	70,199
2026-02-18	Klein Matthew B.	Chief Executive Officer	Informative Sell	7,371	$69.36	$511.25K	387,082
2026-02-18	Gravier Pierre	Chief Financial Officer	Informative Sell	2,992	$69.36	$207.53K	87,318
2026-02-17	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise (Sell)	2,813	$25.69	$72.27K	22,501
2026-01-12	Pauwels Eric	Chief Business Officer	Informative Sell	1,024	$78.70	$80.59K	80,141
2026-01-09	Pauwels Eric	Chief Business Officer	Informative Sell	1,722	$77.41	$133.3K	81,165
2026-01-09	Boulding Mark Elliott	Exec. VP and CLO	Informative Sell	107	$79.52	$8.51K	111,312
2026-01-08	Pauwels Eric	Chief Business Officer	Informative Sell	1,454	$76.45	$111.16K	82,887
2026-01-08	Almstead Neil Gregory	Chief Technical Ops Officer	Informative Sell	59	$76.45	$4.51K	6,791
2026-01-08	Boulding Mark Elliott	Exec. VP and CLO	Informative Sell	1,286	$76.45	$98.31K	113,626
2026-01-08	Golden Lee Scott	EVP & Chief Medical Officer	Informative Sell	866	$76.45	$66.21K	92,428
2026-01-08	Utter Christine Marie	SVP, Chief Accounting Officer	Informative Sell	1,034	$76.45	$79.05K	72,693
2026-01-08	Klein Matthew B.	Chief Executive Officer	Informative Sell	2,514	$76.45	$192.2K	394,453
2026-01-07	Pauwels Eric	Chief Business Officer	Informative Sell	1,352	$77.48	$104.75K	87,489
2026-01-07	Almstead Neil Gregory	Chief Technical Ops Officer	Informative Sell	52	$77.48	$4.03K	6,850
2026-01-07	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise (Sell)	751	$38.10	$28.61K	-
2026-01-07	Golden Lee Scott	EVP & Chief Medical Officer	Informative Sell	642	$77.48	$49.74K	93,294
2026-01-07	Utter Christine Marie	SVP, Chief Accounting Officer	Informative Sell	1,235	$77.45	$95.65K	73,727
2026-01-07	Klein Matthew B.	Chief Executive Officer	Informative Sell	3,016	$77.48	$233.68K	396,967
2026-01-06	Pauwels Eric	Chief Business Officer	Informative Sell	1,789	$76.95	$137.66K	88,841
2026-01-06	Almstead Neil Gregory	Chief Technical Ops Officer	Informative Sell	54	$76.95	$4.16K	6,902
2026-01-06	Boulding Mark Elliott	Exec. VP and CLO	Informative Sell	1,739	$76.95	$133.82K	119,162
2026-01-06	Golden Lee Scott	EVP & Chief Medical Officer	Informative Sell	1,340	$76.95	$103.11K	93,936
2026-01-06	Utter Christine Marie	SVP, Chief Accounting Officer	Informative Sell	1,381	$76.95	$106.27K	74,962
2026-01-06	Klein Matthew B.	Chief Executive Officer	Informative Sell	5,149	$76.95	$396.22K	399,983
2026-01-06	Gravier Pierre	Chief Financial Officer	Informative Sell	2,139	$76.95	$164.6K	90,310
2026-01-05	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise (Sell)	2,266	$39.42	$89.33K	9,063
2026-01-05	Reeve Emma	Director	Option Exercise (Sell)	734	$46.54	$34.16K	-
2026-01-02	Pauwels Eric	Chief Business Officer	RSU Award	50,000	$76.74	$3.84M	50,000
2026-01-02	Zeldis Jerome B	Director	RSU Award	3,475	$76.74	$266.67K	3,475
2026-01-02	Almstead Neil Gregory	Chief Technical Ops Officer	RSU Award	520	-	-	6,956
2026-01-02	Boulding Mark Elliott	Exec. VP and CLO	RSU Award	42,500	$76.74	$3.26M	42,500
2026-01-02	Reeve Emma	Director	RSU Award	3,475	$76.74	$266.67K	3,475
2026-01-02	Golden Lee Scott	EVP & Chief Medical Officer	RSU Award	46,875	$76.74	$3.6M	46,875
2026-01-02	Utter Christine Marie	SVP, Chief Accounting Officer	RSU Award	33,125	$76.74	$2.54M	33,125

■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry